Key points are not available for this paper at this time.
-M, has the ability to reduce tumorigenesis of breast CSCs in vivo. To our knowledge, this is the first report that chiral complexes show significant enantioselectivity on eradicating CSCs.
Qin et al. (Fri,) studied this question.